Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 21:22:11-14.
doi: 10.1016/j.omtm.2021.06.012. eCollection 2021 Sep 10.

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Affiliations
Editorial

Evidence generation and reproducibility in cell and gene therapy research: A call to action

Mohamed Abou-El-Enein et al. Mol Ther Methods Clin Dev. .
No abstract available

PubMed Disclaimer

References

    1. Elsallab M., Levine B.L., Wayne A.S., Abou-El-Enein M. CAR T-cell product performance in haematological malignancies before and after marketing authorisation. Lancet Oncol. 2020;21:e104–e116. - PMC - PubMed
    1. Fucà G., Reppel L., Landoni E., Savoldo B., Dotti G. Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors. Clin. Cancer Res. 2020;26:2444–2451. - PMC - PubMed
    1. Tambuyzer E., Vandendriessche B., Austin C.P., Brooks P.J., Larsson K., Miller Needleman K.I., Valentine J., Davies K., Groft S.C., Preti R. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat. Rev. Drug Discov. 2020;19:93–111. - PubMed
    1. Cavazzana M., Bushman F.D., Miccio A., André-Schmutz I., Six E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat. Rev. Drug Discov. 2019;18:447–462. - PubMed
    1. Feucht J., Abou-El-Enein M. Senolytic CAR T Cells in Solid Tumors and Age-Related Pathologies. Mol. Ther. 2020;28:2108–2110. - PMC - PubMed

Publication types

LinkOut - more resources